Skip to content

Research and Clinical Application of an Early Diagnosis System for Alzheimer's Disease Based on Retina-Brain Combined Biomarkers

Research and Clinical Application of an Early Diagnosis System for Alzheimer's Disease Based on Retina-Brain Combined Biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122638
Enrollment
Unknown
Registered
2026-04-16
Start date
2026-04-25
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Interventions

Case Group (AD Patients):None
Control Group (Non-AD Population):None

Sponsors

Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Educational attainment of primary school or above, aged 55–100 years, with no restrictions on marital status or occupation; 2. Adequate vision and hearing to complete the examinations; 3. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe physical diseases; 2. Mental illnesses that prevent the subject from cooperating with assessments; 3. Neurological disorders including stroke, traumatic brain injury, epilepsy, etc.; 4. Subjects with disturbance of consciousness, language impairment, or physical disability who cannot cooperate with relevant evaluations; 5. Life-threatening severe illnesses; 6. Severe visual or hearing impairment, or other conditions that interfere with communication.

Design outcomes

Primary

MeasureTime frame
Metabolite profile of blood specimens;Microbiota characteristics of fecal specimens;Score on the Montreal Cognitive Assessment-Basic (MoCA-B);

Secondary

MeasureTime frame
General demographic data (age, smoking history, drinking history, educational level, marital status, history of hypertension, history of diabetes);Body measurement indicators;Laboratory test indicators (blood routine, liver function, kidney function, blood lipid, thyroid function, inflammation and metabolic indicators);

Countries

China

Contacts

Public ContactTao Yumin

Affiliated Kangning Hospital of Ningbo University

taoym@nbcdc.org.cn+86 574 87273527

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026